BAKER BROS. ADVISORS LP 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
BAKER BROS. ADVISORS LP | 4,916,095 9.800% |
4,916,095 (New Position) |
Filing |